DAWN KNAPP: Open Payments
NPI 1114225463 · HAYS, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$145 in 7 payments from 5 companies in 2025. Trend: 2023 $188 · 2024 $242 · 2025 $145
Food & beverage: $145
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
| Corcept Therapeutics | 1 | $15 |
Products named: EVENITY, REXULTI, REPATHA, VRAYLAR, Ozempic, Korlym.
Industry payments across KS — which companies pay providers there.
